Dissociation of the increased formation of cardiac adenosine 3',5'-monophosphate from the positive inotropic effect of norepinephrine.
D000227:Adenine Nucleotides / Q000378:metabolism*; D000818:Animals; D000242:Cyclic AMP / Q000032:analysis / Q000378:metabolism; D066298:In Vitro Techniques; D008297:Male; D008729:Methoxamine / Q000494:pharmacology; D009119:Muscle Contraction / Q000187:drug effects*; D009206:Myocardium / Q000201:enzymology* / Q000378:metabolism; D009638:Norepinephrine / Q000008:administration & dosage / Q000494:pharmacology*; D010477:Perfusion; D051381:Rats; D013997:Time Factors
D000227:Adenine Nucleotides; D000242:Cyclic AMP; D008729:Methoxamine; D009638:Norepinephrine